CalciMedica, Inc. (NASDAQ:CALC) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of units of common stock or pre-funded warrants with Series A and Series B warrant rights Announced: US$15M–US$49M · US$0.8033 a unit · a right to receive one Series A warrant exercisable at $0.8033 per share and one… · Guggenheim Securities, LLC Dealers: Guggenheim Securities, LLC (lead) Insiders: Members of the Board of Directors and management team participate, priced at or above the Nasdaq Consolidated Closing Bid Price as of June 23, 2026 Use of proceeds: Pulmonary hypertension program: Phase 1b study of Auxora in PAH, IND-enabling work for CM5480, and general corporate purposes | Jun 24, 2026 |